No trading signal from these routine initial filings. Monitor for future Form 4 filings for insider transactions that may indicate sentiment.
Price Chart
Executive Summary
CEO Daphne Zohar and director Sandra E. Peterson filed initial beneficial ownership statements (Form 3) for Seaport Therapeutics, disclosing their holdings of common stock and stock options. These are routine initial filings required upon becoming reporting persons, with no material financial impact or change in company operations.
Key Facts
- CEO Daphne Zohar filed Form 3 disclosing 1,194,001 shares of common stock and options to buy 2,311,259 shares at $3.05, 182,485 shares at $7.39, and 271,813 shares at $10.31.
- Director Sandra E. Peterson filed Form 3 disclosing options to buy 77,042 shares at $7.39 and 12,258 shares at $10.31.
- Both filings include standard powers of attorney for Section 16 compliance.
- Filing date: April 30, 2026; period of report: April 30, 2026.
Financial Impact
No financial impact; routine insider ownership disclosure.
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (SPTX) — Batch item 1 | 0001193125-26-198531 |
| Document: 0001193125-26-198531-index-headers.html | 0001193125-26-198532 |
| Document: 0001193125-26-198531-index.html | 0001193125-26-198531 |
| Document: 0001193125-26-198531.txt | 0001193125-26-198531 |
| 3 Filing (SPTX) — Batch item 5 | 0001193125-26-198532 |
| Document: 0001193125-26-198532-index-headers.html | 0001193125-26-198531 |
| Document: 0001193125-26-198532-index.html | 0001193125-26-198531 |
| Document: 0001193125-26-198532.txt | 0001193125-26-198531 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 3, 2026 12w ago | 8-K | $20.65 | awaiting T+60 | — | $21.28 (+3.05%) |
Jun 8, 2026 20w ago | 8-K | $16.20 $23.61 | ▲ +45.74% | ▲ +42.69% | $21.28 (+31.36%) |
May 6, 2026 24w ago | 3 | $15.50 $20.65 | ▲ +33.23% | ▲ +29.39% | $21.28 (+37.29%) |
May 1, 2026 25w ago | 424B4 | $17.00 $19.74 | ▲ +16.12% | ▲ +14.26% | $21.28 (+25.18%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $21.28 (+7.26%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $21.28 (+7.26%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $21.28 (+7.26%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $21.28 (+7.26%) |
Apr 30, 2026 25w ago | 3 | $19.84 $19.90 | ▲ +0.30% | ▼ −2.77% | $21.28 (+7.26%) |
Apr 27, 2026 26w ago | S-1/A | — | awaiting T+60 | — | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers